Peptide Glossary: 75 Terms Every Beginner Should Know

Reading time
11 min
Published on
June 12, 2026
Updated on
June 12, 2026
Peptide Glossary: 75 Terms Every Beginner Should Know

Introduction

A peptide is a short chain of amino acids linked by peptide bonds, generally 2 to 50 units long, and it sits between single amino acids and full proteins in size. That one definition unlocks most of the vocabulary in this field. Once you know peptides are small protein fragments that signal cells to do specific things, the rest of the terms start to connect.

This glossary collects 75 terms a beginner runs into when researching peptides for metabolic health, recovery, or longevity. Some terms are basic biochemistry. Others name specific peptides, and a few belong to the pharmacy and regulatory world. Where the human evidence is genuinely limited, the entry says so plainly, because honest framing is more useful than hype.

At TrimRx, we think understanding the language is part of understanding your options. If a peptide or GLP-1 program might fit your goals, you can take the free assessment quiz and let a clinician weigh in.

At TrimRx, we believe that understanding your options is the first step toward a more manageable health journey. You can take the free assessment quiz if you’re ready to see whether a personalized program is a fit for you.

Group 1: The Basics of Peptide Biology

This group covers the foundational terms. Get these and the named-peptide entries later make far more sense, because they all build on the same chemistry.

Quick Answer: A peptide is a short chain of amino acids, typically between 2 and 50, joined by peptide bonds. Anything longer is usually called a protein.

  1. Peptide. A short chain of amino acids, typically 2 to 50, joined by peptide bonds. Smaller than a protein, larger than a single amino acid.
  2. Amino acid. The building block of peptides and proteins. There are 20 standard amino acids the body uses to assemble these chains.
  3. Peptide bond. The chemical link between two amino acids, formed when one acid’s carboxyl group joins another’s amino group, releasing water.
  4. Protein. A long amino acid chain, usually more than 50 units, often folded into a complex shape. Peptides are smaller fragments of the same chemistry.
  5. Polypeptide. A longer peptide chain, often used as the bridge term between peptide and protein.
  6. Sequence. The specific order of amino acids in a peptide. The sequence determines what the peptide does, like letters spelling a word.
  7. Receptor. A protein on or in a cell that a peptide binds to, triggering a response. Peptides work by docking with the right receptor.
  8. Agonist. A molecule that binds a receptor and activates it. Most therapeutic peptides act as agonists for a target receptor.
  9. Antagonist. A molecule that binds a receptor and blocks it, the opposite of an agonist.
  10. Signaling peptide. A peptide whose job is to carry a message between cells, prompting actions like growth, repair, or appetite change.
  11. Hormone. A signaling molecule released into the blood. Many hormones, including insulin and GLP-1, are peptides.
  12. Endogenous. Made inside the body. Endogenous GLP-1, for example, is the version your gut produces naturally.
  13. Exogenous. Introduced from outside the body, such as an injected peptide.
  14. Synthetic peptide. A peptide made in a lab rather than extracted from tissue, which is how most modern therapeutic peptides are produced.
  15. Analog. A modified version of a natural peptide, changed to last longer or bind more strongly. Semaglutide is an analog of natural GLP-1.

Group 2: Named Peptides You Will Encounter

These are the specific peptides that come up most in metabolic, recovery, and longevity conversations. Evidence quality varies widely between them, and the entries note where human data is limited.

  1. GLP-1. Glucagon-like peptide-1, a gut hormone that triggers insulin release and reduces appetite. The basis for semaglutide and tirzepatide.
  2. Semaglutide. A long-acting GLP-1 analog used for weight and glucose management, studied in the STEP trials (Wilding 2021, NEJM).
  3. Tirzepatide. A dual GIP and GLP-1 receptor agonist, studied in SURMOUNT-1 (Jastreboff 2022, NEJM). Often called a twincretin.
  4. GIP. Glucose-dependent insulinotropic polypeptide, the second gut hormone tirzepatide targets alongside GLP-1.
  5. Liraglutide. An earlier, daily GLP-1 analog, the active molecule in Saxenda® and Victoza®.
  6. BPC-157. A peptide studied mostly in animals for tissue repair, with limited human data. It was removed from the FDA’s Category 2 bulk substances list in April 2026, changing its compounding status. Much of the evidence traces to Sikiric and colleagues.
  7. TB-500. A synthetic fragment related to thymosin beta-4, marketed for recovery. Human clinical data is sparse.
  8. GHK-Cu. A copper-binding peptide studied for skin and wound healing, with much of the foundational work from Pickart. Stronger evidence sits in topical and lab settings than in injection.
  9. CJC-1295. A growth hormone-releasing hormone analog used to raise growth hormone output. Mostly studied in small trials.
  10. Ipamorelin. A growth hormone secretagogue often paired with CJC-1295. Limited large-scale human data.
  11. Sermorelin. A growth hormone-releasing hormone analog with a longer clinical history, once used in pediatric growth testing.
  12. Tesamorelin. A growth hormone-releasing hormone analog with FDA approval for a specific HIV-related fat condition, so it has real clinical data behind it.
  13. PT-141. Also called bremelanotide, a peptide that acts on melanocortin receptors, FDA-approved for a sexual health indication.
  14. Melanotan II. A melanocortin agonist marketed for tanning and libido, sold largely outside approved channels. Safety data is limited.
  15. Thymosin alpha-1. An immune-modulating peptide with clinical use in some countries for immune support.
  16. Epitalon. A short peptide promoted for longevity, with most claims resting on small Russian studies and limited independent replication.
  17. AOD-9604. A fragment of human growth hormone marketed for fat loss. Human results have been underwhelming in published work.
  18. NAD+. Not a peptide but a coenzyme often grouped with peptide therapies. Studied for cellular energy and aging (Yoshino 2021, Science).
  19. Insulin. The original therapeutic peptide hormone, in clinical use since 1922 and the proof that peptides can be drugs.
  20. Glucagon. A peptide hormone that raises blood sugar, the counterpart to insulin.
  21. Oxytocin. A peptide hormone involved in bonding and labor, also a marketed therapeutic in some settings.

Group 3: The Lab and Pharmacy Side

These terms describe how peptides are made, prepared, and dispensed. They matter most when you are evaluating a source or reading a label.

  1. Compounding. Preparing a customized medication for an individual patient, done by licensed pharmacies under specific rules.
  2. 503A pharmacy. A state-licensed compounding pharmacy that prepares medications for individual patients based on a prescription.
  3. 503B outsourcing facility. A federally registered compounder that can make larger batches under tighter manufacturing standards.
  4. Reconstitution. Mixing a powdered peptide with a sterile liquid to make an injectable solution. Many peptides ship as powder for stability.
  5. Lyophilized. Freeze-dried. Lyophilized peptide powder stays stable longer than a premixed solution.
  6. Bacteriostatic water. Sterile water with a preservative, used to reconstitute peptides for multi-dose vials.
  7. Sterile water. Water without preservative, sometimes used for single-dose reconstitution.
  8. Vial. The small glass container holding the peptide, sealed with a rubber stopper for repeated draws.
  9. Beyond-use date. The date after which a compounded peptide should not be used, set by the pharmacy based on stability.
  10. Potency. How much active peptide is actually present, which can degrade with heat, light, or time.
  11. Purity. The share of the product that is the intended peptide versus impurities. Third-party testing reports purity.
  12. Certificate of analysis. A lab document stating a batch’s purity and identity. Reputable sources provide one.
  13. HPLC. High-performance liquid chromatography, the standard lab method for measuring peptide purity.
  14. Mass spectrometry. A technique that confirms a peptide’s identity by measuring its molecular weight.
  15. USP standards. Quality standards from the United States Pharmacopeia that compounding pharmacies follow.
  16. Excipient. An inactive ingredient added to a formulation, such as a preservative or stabilizer.

Group 4: Dosing and Delivery

These terms cover how peptides actually get into the body and how doses are described. They come up the moment you start a protocol.

  1. Subcutaneous injection. An injection into the fat layer just under the skin, the most common route for peptides.
  2. Intramuscular injection. An injection into muscle, used for some peptides but less common in self-administered protocols.
  3. Insulin syringe. A fine, short syringe marked in units, the standard tool for subcutaneous peptide dosing.
  4. U-100 syringe. A syringe scaled so 100 units equals 1 mL, the usual scale for peptide and GLP-1 dosing.
  5. Units. The marks on an insulin syringe. Your dosing card converts your milligram or microgram dose into units.
  6. Microgram (mcg). One thousandth of a milligram. Many peptides dose in micrograms rather than milligrams.
  7. Milligram (mg). A common dose unit for GLP-1 peptides and the total content of many vials.
  8. Concentration. The amount of peptide per milliliter, which sets how many units a given dose requires.
  9. Titration. Gradually increasing a dose so the body adjusts, standard for GLP-1 peptides.
  10. Loading phase. An initial higher-frequency dosing period some recovery peptide protocols use, though evidence for it is limited.
  11. Maintenance dose. The steady dose held after titration once the desired effect is reached.
  12. Cycling. Running a peptide for a set period then pausing, a common practice with growth hormone secretagogues.
  13. Half-life. The time for half a dose to clear the body. A longer half-life means less frequent dosing.
  14. Bioavailability. The share of a dose that reaches circulation. Injected peptides have higher bioavailability than oral ones, which often break down in the gut.

Key Takeaway: Many popular peptides have limited human data, so this glossary flags where evidence is strong and where it is thin.

Group 5: Safety and Regulation

These terms help you judge whether a peptide and its source are legitimate. In a field with uneven oversight, this vocabulary protects you.

  1. FDA approval. Formal clearance that a drug is safe and effective for a stated use. Most research peptides lack it.
  2. Category 2 bulk substances. An FDA list of bulk drug substances with safety questions for compounding. BPC-157 was removed from this list in April 2026.
  3. Research chemical. A label some sellers use to dodge medical regulation. Products sold this way are not meant for human use.
  4. Gray market. Sales channels that operate outside clear medical or legal oversight, where quality is unverified.
  5. LegitScript certification. A third-party program that verifies a telehealth or pharmacy operator meets legal and safety standards.
  6. Adverse event. Any negative reaction to a peptide, from injection-site irritation to systemic effects.
  7. Contraindication. A condition that makes a peptide unsafe for you, such as certain medical histories.
  8. Off-label use. Using an approved drug for a purpose it was not approved for, which is legal but carries less evidence.
  9. Limited human data. A phrase you should expect often. Many peptides have animal or small-study evidence only, so claims outrun proof.

How to Use This Glossary in Practice

Treat this as a lookup table, not a study sheet. When a consult, a label, or an article uses a term you are unsure about, find it here. The most useful habit is checking whether a peptide has real human evidence or only animal data, because that single distinction separates well-studied options from hopeful ones. A TrimRX clinician can tell you which peptides have the evidence to back the claims and which are still experimental, which is exactly the conversation the free assessment quiz opens.

FAQ

What Is the Difference Between a Peptide and a Protein?

Size. A peptide is a short amino acid chain, usually 2 to 50 units. A protein is longer, often more than 50 units, and folded into a complex shape. They share the same chemistry, but peptides are the smaller fragments, which is why they can act as quick signals between cells.

Why Do So Many Peptides Have Limited Human Data?

Because rigorous human trials are expensive and slow, and many peptides are sold before that research is done. Animal studies or small pilot trials often exist, but they do not prove safety or effectiveness in people. That gap is why honest sources flag limited human data instead of overselling.

What Changed with BPC-157 in 2026?

BPC-157 was removed from the FDA’s Category 2 bulk substances list in April 2026. That change affects its compounding status. Most of the peptide’s evidence still comes from animal work, much of it from Sikiric and colleagues, so human data remains limited despite the regulatory shift.

Is NAD+ a Peptide?

No. NAD+ is a coenzyme, not a peptide, but it often appears alongside peptide therapies in longevity discussions. It has been studied for cellular energy and aging, including work published by Yoshino and colleagues in Science in 2021.

What Does Reconstitution Mean and Why Is It Needed?

Reconstitution is mixing a freeze-dried peptide powder with a sterile liquid to make it injectable. Many peptides ship as powder because the dry form stays stable far longer than a premixed solution. Once reconstituted, the peptide has a shorter beyond-use date and usually needs refrigeration.

How Can I Tell If a Peptide Source Is Legitimate?

Look for a licensed compounding pharmacy, a certificate of analysis showing purity, and operator credentials like LegitScript certification. Avoid anything labeled a research chemical or sold on the gray market, since those are not intended for human use and their quality is unverified.

Disclaimer: This content is for informational purposes only and does not constitute medical advice. It is not intended to diagnose, treat, cure, or prevent any disease or condition. Individual results may vary. Always consult a qualified healthcare professional before starting any weight loss program or medication.

Transforming Lives, One Step at a Time

Patients on TrimRx can maintain the WEIGHT OFF
Start Your Treatment Now!

Keep reading

10 min read

Women’s Peptide Stack: What Actually Works for Female Biology

Introduction There is no magic women-only peptide, but there is a women-specific way to build a stack: start from goals women most often bring…

11 min read

Wolverine Peptide Stack: BPC-157 and TB-500 for Recovery

The Wolverine peptide stack is the combination of BPC-157 and TB-500, the two most popular tissue repair peptides in the wellness world.

10 min read

Why Do Peptides Need Refrigeration?

Peptides need refrigeration because they are fragile molecules that break down over time, and cold dramatically slows that breakdown.

Stay on Track

Join our community and receive:
Expert tips on maximizing your GLP-1 treatment.
Exclusive discounts on your next order.
Updates on the latest weight-loss breakthroughs.